National HIV Reporting Approaches, But Privacy Remains Paramount

TIME TO RETHINK: The old discussions about reporting HIV infection must be reviewed in light of a changing epidemic, says CDC's John Ward. As the AIDS epidemic enters a new phase of changing demographics and combination drug therapy, support is mounting for a national system of HIV case reporting. Even some civil rights activists who previously opposed HIV reporting now are admitting the need for it to help contain the elusive disease. However, the long-debated question of whether HIV-positive

Written bySteve Bunk
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share


TIME TO RETHINK: The old discussions about reporting HIV infection must be reviewed in light of a changing epidemic, says CDC's John Ward.
As the AIDS epidemic enters a new phase of changing demographics and combination drug therapy, support is mounting for a national system of HIV case reporting. Even some civil rights activists who previously opposed HIV reporting now are admitting the need for it to help contain the elusive disease. However, the long-debated question of whether HIV-positive people should be identified by name remains to be resolved, and the issue may yet pose ethical concerns for some researchers.

"We're at a turning point of this epidemic," notes John Ward, chief of HIV/AIDS surveillance in the Atlanta-based Centers for Disease Control and Prevention (CDC). "After 16 years, for the first time we're beginning to change, in a profound way, how we monitor it. Because of that, all the old ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies